Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

No abstract is available for this paper.

• Publication year

  2017

• Venue

  World Journal of Biological Psychiatry

• Publication date

  2017-07-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15622975.2016.1224929PMID 27782767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research.

  2016cited by this paper
• Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

  2016cited by this paper
• Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

  2016cited by this paper
• A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium

  2016cited by this paper
• Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics

  2016cited by this paper
• Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

  2016cited by this paper
• Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study.

  2016cited by this paper
• A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue.

  2016cited by this paper
• Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke

  2015cited by this paper
• [Neurobiology of schizophrenia: new findings from the structure to the molecules].

  2015cited by this paper
• Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

  2015cited by this paper
• Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology

  2015influential reference
• Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post‐mortem brain of patients with schizophrenia and Psychotic bipolar disorder

  2015cited by this paper
• Brain disorders? Precisely

  2015cited by this paper
• Inflammation in schizophrenia: A question of balance.

  2015cited by this paper
• Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis.

  2015cited by this paper
• Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains

  2015cited by this paper
• BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues.

  2015cited by this paper
• DNA methylation patterns of protein-coding genes and long non-coding RNAs in males with schizophrenia

  2015cited by this paper
• Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

  2015cited by this paper
• Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications

  2015cited by this paper
• A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder

  2015cited by this paper
• Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation

  2015cited by this paper
• Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications.

  2015cited by this paper
• DNA methylation patterns of protein coding genes and long noncoding RNAs in female schizophrenic patients.

  2015cited by this paper
• Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.

  2015cited by this paper
• Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood

  2014cited by this paper
• Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity

  2014influential reference
• Seroprevalence of autoantibodies against brain antigens in health and disease

  2014influential reference
• Examining peripheral DNA methylation in behavioral epigenetic and epigenetic psychiatry: opportunities and challenges.

  2014cited by this paper
• Refinement of schizophrenia GWAS loci using methylome-wide association data

  2014cited by this paper
• Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.

  2014cited by this paper
• Kynurenines in CNS disease: regulation by inflammatory cytokines

  2014cited by this paper
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cited by this paper
• Perspective: Revealing molecular secrets

  2014cited by this paper
• Aberrant DNA Methylation of Blood in Schizophrenia by Adjusting for Estimated Cellular Proportions

  2014cited by this paper
• Human Cerebrospinal Fluid Fatty Acid Levels Differ between Supernatant Fluid and Brain-Derived Nanoparticle Fractions, and Are Altered in Alzheimer's Disease

  2014cited by this paper
• Pro-/Antiinflammatory Dysregulation in Early Psychosis: Results from a 1-Year Follow-Up Study

  2014cited by this paper
• Schizophrenia: from dopaminergic to glutamatergic interventions.

  2014cited by this paper
• Changes in gene expression and methylation in the blood of patients with first-episode psychosis.

  2014cited by this paper
• Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots.

  2014cited by this paper
• Toward the Identification of Peripheral Epigenetic Biomarkers of Schizophrenia

  2014influential reference
• Analytical tools and current challenges in the modern era of neuroepigenomics

  2014cited by this paper
• Cross-tissue methylomic profiling strongly implicates a role for cortex-specific deregulation of ANK1 in Alzheimer’s disease neuropathology

  2014cited by this paper
• Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia

  2014cited by this paper
• DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.

  2014cited by this paper
• Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults.

  2014cited by this paper
• Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice

  2014cited by this paper
• Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited.

  2014cited by this paper
• Myelination, oligodendrocytes, and serious mental illness

  2014cited by this paper
• Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder

  2014cited by this paper
• Male-Specific Association between Dopamine Receptor D4 Gene Methylation and Schizophrenia

  2014cited by this paper
• Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective.

  2014cited by this paper
• The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.

  2014cited by this paper
• Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.

  2014cited by this paper
• A role for noncoding variation in schizophrenia.

  2014cited by this paper
• Methylation patterns in whole blood correlate with symptoms in schizophrenia patients.

  2014cited by this paper
• Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients

  2014cited by this paper
• Expression of microRNAs and Other Small RNAs in Prefrontal Cortex in Schizophrenia, Bipolar Disorder and Depressed Subjects

  2014cited by this paper
• Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

  2014cited by this paper
• Molecular Profiles of Parvalbumin-Immunoreactive Neurons in the Superior Temporal Cortex in Schizophrenia

  2014cited by this paper
• Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways.

  2014cited by this paper
• When less is more – microRNAs and psychiatric disorders

  2014cited by this paper
• Hypomethylation of the paternally inherited LRRTM1 promoter linked to schizophrenia

  2014cited by this paper
• A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.

  2014cited by this paper
• Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.

  2014cited by this paper
• Epigenetics as a basis for diagnosis of neurodevelopmental disorders: challenges and opportunities

  2014cited by this paper
• Myelination and oligodendrocyte functions in psychiatric diseases.

  2014cited by this paper
• Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics.

  2014cited by this paper
• The impact of environmental factors in severe psychiatric disorders

  2014influential reference
• Molecular Profiles of Pyramidal Neurons in the Superior Temporal Cortex in Schizophrenia

  2014cited by this paper
• MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review

  2013cited by this paper
• Nuclear calcium signalling in the regulation of brain function

  2013cited by this paper
• Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia.

  2013cited by this paper
• Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease[S]

  2013cited by this paper
• The Association between Health System Development and the Burden of Cardiovascular Disease: An Analysis of WHO Country Profiles

  2013cited by this paper
• Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

  2013cited by this paper
• RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.

  2013influential reference
• TCF4 (e2‐2; ITF2): A schizophrenia‐associated gene with pleiotropic effects on human disease

  2013cited by this paper
• Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia

  2013cited by this paper
• Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome.

  2013cited by this paper
• Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors

  2013cited by this paper
• Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia.

  2013cited by this paper
• Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

  2013cited by this paper
• The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia

  2013cited by this paper
• Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia

  2013cited by this paper
• Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters.

  2013cited by this paper
• Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.

  2013cited by this paper
• Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown.

  2013influential reference
• Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia.

  2013cited by this paper
• Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients

  2013cited by this paper
• Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia

  2013cited by this paper
• Anti-inflammatory treatment in schizophrenia.

  2013cited by this paper
• MicroRNAs as biomarkers for CNS disease

  2013influential reference
• FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors.

  2013cited by this paper
• Omega-3 fatty acids and schizophrenia: evidences and recommendations.

  2013cited by this paper
• Biomarkers for Psychiatric Disorders: Where Are We Standing?

  2013cited by this paper
• Inflammation and schizophrenia.

  2013cited by this paper

• Dynamic mode decomposition of resting-state fMRI revealing abnormal brain region features in schizophrenia

  2026cites this paper
• Alteration of microRNA expression in lymphocytes in patients with first-episode schizophrenia

  2025cites this paper
• Electrophysiological Features of Late-Stage Language Processing in Patients with Schizophrenia

  2025cites this paper
• The role of mindfulness training supported by virtual reality in the nonpharmacological treatment of schizophrenia-research design

  2025cites this paper
• Changing trends in the global burden of mental disorders from 1990 to 2019 and predicted levels in 25 years

  2023cites this paper
• Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects

  2022cites this paper
• Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets.

  2022cites this paper
• Biological hypotheses, risk factors, and biomarkers of schizophrenia.

  2022cites this paper
• BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review

  2021cites this paper
• Effects of the co‐administration of MK‐801 and clozapine on MiRNA expression profiles in rats

  2021cites this paper
• The Influence of Filters on EEG-ERP Testing: Analysis of Motor Cortex in Healthy Subjects

  2021cites this paper
• Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function

  2021cites this paper
• Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis.

  2020cites this paper
• Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings

  2020cites this paper
• Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders

  2020cites this paper
• Bioactive and Inflammatory Markers in Emerging Psychotic Disorders

  2019cites this paper
• Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress

  2019cites this paper
• Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia

  2019cites this paper
• Complement Pathway Changes in Childhood are Associated with Incidence and Persistence of Psychotic Experiences in Adolescence: Evidence from the ALSPAC Birth Cohort.

  2019cites this paper
• “Now Is a Time for Optimism”: The Politics of Personalized Medicine in Mental Health Research

  2019cites this paper
• Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia

  2019cites this paper
• The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism

  2019cites this paper
• Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics.

  2019cites this paper
• Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks

  2019cites this paper
• Future paths in psychopharmacology


  2019cites this paper
• Von psychischen Störungen zu daten-getriebenen Biotypen?

  2019cites this paper
• Controversies in psychiatry

  2018cites this paper
• Modeling Schizophrenia with Human Stem Cells

  2018cites this paper
• Transcranial sonography in psychiatry as a potential tool in diagnosis and research

  2018cites this paper
• Trends in Schizophrenia Diagnosis and Treatment

  2018cites this paper
• The role of genetic variation of human metabolism for BMI, mental traits and mental disorders

  2018cites this paper
• Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia

  2017cites this paper
• Transdiagnostic Extension of Delusions: Schizophrenia and Beyond

  2017cites this paper
• Variability of DNA Methylation within Schizophrenia Risk Loci across Subregions of Human Hippocampus

  2017cites this paper
• Identification of Risk-Conferring Genes of Schizophrenia Using Endophenotypes

  2017cites this paper
• HDAC1 links early life stress to schizophrenia-like phenotypes

  2017cites this paper
• Social challenges of contemporary psychiatry.

  2017cites this paper
• From basic research to personalized medicine

  2016cites this paper